Highlights

[PHARMA] YoY Quarter Result on 2018-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 16-May-2018
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2018
Quarter 31-Mar-2018  [#1]
Profit Trend QoQ -     -18.96%    YoY -     -7.07%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 819,921 786,108 617,923 618,294 559,195 471,904 468,672 9.76%
  YoY % 4.30% 27.22% -0.06% 10.57% 18.50% 0.69% -
  Horiz. % 174.95% 167.73% 131.85% 131.92% 119.31% 100.69% 100.00%
PBT 30,880 30,243 28,707 27,777 26,538 38,612 38,159 -3.46%
  YoY % 2.11% 5.35% 3.35% 4.67% -31.27% 1.19% -
  Horiz. % 80.92% 79.26% 75.23% 72.79% 69.55% 101.19% 100.00%
Tax -8,465 -10,595 -11,118 -8,519 -8,068 -6,686 -11,513 -4.99%
  YoY % 20.10% 4.70% -30.51% -5.59% -20.67% 41.93% -
  Horiz. % 73.53% 92.03% 96.57% 73.99% 70.08% 58.07% 100.00%
NP 22,415 19,648 17,589 19,258 18,470 31,926 26,646 -2.84%
  YoY % 14.08% 11.71% -8.67% 4.27% -42.15% 19.82% -
  Horiz. % 84.12% 73.74% 66.01% 72.27% 69.32% 119.82% 100.00%
NP to SH 22,399 19,617 17,586 18,923 18,379 31,794 26,217 -2.59%
  YoY % 14.18% 11.55% -7.07% 2.96% -42.19% 21.27% -
  Horiz. % 85.44% 74.83% 67.08% 72.18% 70.10% 121.27% 100.00%
Tax Rate 27.41 % 35.03 % 38.73 % 30.67 % 30.40 % 17.32 % 30.17 % -1.58%
  YoY % -21.75% -9.55% 26.28% 0.89% 75.52% -42.59% -
  Horiz. % 90.85% 116.11% 128.37% 101.66% 100.76% 57.41% 100.00%
Total Cost 797,506 766,460 600,334 599,036 540,725 439,978 442,026 10.33%
  YoY % 4.05% 27.67% 0.22% 10.78% 22.90% -0.46% -
  Horiz. % 180.42% 173.40% 135.81% 135.52% 122.33% 99.54% 100.00%
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.23%
  YoY % -33.81% 0.76% -3.59% 5.52% -2.32% 2.55% -
  Horiz. % 67.97% 102.68% 101.91% 105.70% 100.17% 102.55% 100.00%
Dividend
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Div 15,673 15,630 12,991 10,368 10,354 18,123 10,352 7.15%
  YoY % 0.28% 20.32% 25.29% 0.14% -42.87% 75.07% -
  Horiz. % 151.41% 150.99% 125.49% 100.16% 100.02% 175.07% 100.00%
Div Payout % 69.98 % 79.68 % 73.87 % 54.79 % 56.34 % 57.00 % 39.49 % 10.00%
  YoY % -12.17% 7.87% 34.82% -2.75% -1.16% 44.34% -
  Horiz. % 177.21% 201.77% 187.06% 138.74% 142.67% 144.34% 100.00%
Equity
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.23%
  YoY % -33.81% 0.76% -3.59% 5.52% -2.32% 2.55% -
  Horiz. % 67.97% 102.68% 101.91% 105.70% 100.17% 102.55% 100.00%
NOSH 261,229 260,505 259,821 259,219 258,859 258,908 258,805 0.16%
  YoY % 0.28% 0.26% 0.23% 0.14% -0.02% 0.04% -
  Horiz. % 100.94% 100.66% 100.39% 100.16% 100.02% 100.04% 100.00%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 2.73 % 2.50 % 2.85 % 3.11 % 3.30 % 6.77 % 5.69 % -11.51%
  YoY % 9.20% -12.28% -8.36% -5.76% -51.26% 18.98% -
  Horiz. % 47.98% 43.94% 50.09% 54.66% 58.00% 118.98% 100.00%
ROE 6.40 % 3.71 % 3.35 % 3.48 % 3.56 % 6.02 % 5.09 % 3.89%
  YoY % 72.51% 10.75% -3.74% -2.25% -40.86% 18.27% -
  Horiz. % 125.74% 72.89% 65.82% 68.37% 69.94% 118.27% 100.00%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 313.87 301.76 237.83 238.52 216.02 182.27 181.09 9.59%
  YoY % 4.01% 26.88% -0.29% 10.42% 18.52% 0.65% -
  Horiz. % 173.32% 166.64% 131.33% 131.71% 119.29% 100.65% 100.00%
EPS 8.57 7.53 6.77 7.30 7.10 12.28 10.13 -2.75%
  YoY % 13.81% 11.23% -7.26% 2.82% -42.18% 21.22% -
  Horiz. % 84.60% 74.33% 66.83% 72.06% 70.09% 121.22% 100.00%
DPS 6.00 6.00 5.00 4.00 4.00 7.00 4.00 6.98%
  YoY % 0.00% 20.00% 25.00% 0.00% -42.86% 75.00% -
  Horiz. % 150.00% 150.00% 125.00% 100.00% 100.00% 175.00% 100.00%
NAPS 1.3400 2.0300 2.0200 2.1000 1.9930 2.0400 1.9900 -6.37%
  YoY % -33.99% 0.50% -3.81% 5.37% -2.30% 2.51% -
  Horiz. % 67.34% 102.01% 101.51% 105.53% 100.15% 102.51% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 313.87 300.93 236.54 236.69 214.06 180.65 179.41 9.76%
  YoY % 4.30% 27.22% -0.06% 10.57% 18.49% 0.69% -
  Horiz. % 174.95% 167.73% 131.84% 131.93% 119.31% 100.69% 100.00%
EPS 8.57 7.51 6.73 7.24 7.04 12.17 10.04 -2.60%
  YoY % 14.11% 11.59% -7.04% 2.84% -42.15% 21.22% -
  Horiz. % 85.36% 74.80% 67.03% 72.11% 70.12% 121.22% 100.00%
DPS 6.00 5.98 4.97 3.97 3.96 6.94 3.96 7.16%
  YoY % 0.33% 20.32% 25.19% 0.25% -42.94% 75.25% -
  Horiz. % 151.52% 151.01% 125.51% 100.25% 100.00% 175.25% 100.00%
NAPS 1.3400 2.0244 2.0091 2.0838 1.9749 2.0219 1.9715 -6.23%
  YoY % -33.81% 0.76% -3.58% 5.51% -2.32% 2.56% -
  Horiz. % 67.97% 102.68% 101.91% 105.70% 100.17% 102.56% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 -
Price 1.2600 2.2700 4.2800 4.8900 5.7600 6.0000 4.4600 -
P/RPS 0.40 0.75 1.80 2.05 2.67 3.29 2.46 -26.10%
  YoY % -46.67% -58.33% -12.20% -23.22% -18.84% 33.74% -
  Horiz. % 16.26% 30.49% 73.17% 83.33% 108.54% 133.74% 100.00%
P/EPS 14.69 30.14 63.23 66.99 81.13 48.86 44.03 -16.71%
  YoY % -51.26% -52.33% -5.61% -17.43% 66.05% 10.97% -
  Horiz. % 33.36% 68.45% 143.61% 152.15% 184.26% 110.97% 100.00%
EY 6.81 3.32 1.58 1.49 1.23 2.05 2.27 20.07%
  YoY % 105.12% 110.13% 6.04% 21.14% -40.00% -9.69% -
  Horiz. % 300.00% 146.26% 69.60% 65.64% 54.19% 90.31% 100.00%
DY 4.76 2.64 1.17 0.82 0.69 1.17 0.90 31.96%
  YoY % 80.30% 125.64% 42.68% 18.84% -41.03% 30.00% -
  Horiz. % 528.89% 293.33% 130.00% 91.11% 76.67% 130.00% 100.00%
P/NAPS 0.94 1.12 2.12 2.33 2.89 2.94 2.24 -13.46%
  YoY % -16.07% -47.17% -9.01% -19.38% -1.70% 31.25% -
  Horiz. % 41.96% 50.00% 94.64% 104.02% 129.02% 131.25% 100.00%
Price Multiplier on Announcement Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 19/05/20 16/05/19 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 -
Price 1.8800 2.3600 4.0700 4.7200 5.6000 6.9100 4.7000 -
P/RPS 0.60 0.78 1.71 1.98 2.59 3.79 2.60 -21.66%
  YoY % -23.08% -54.39% -13.64% -23.55% -31.66% 45.77% -
  Horiz. % 23.08% 30.00% 65.77% 76.15% 99.62% 145.77% 100.00%
P/EPS 21.93 31.34 60.13 64.66 78.87 56.27 46.40 -11.73%
  YoY % -30.03% -47.88% -7.01% -18.02% 40.16% 21.27% -
  Horiz. % 47.26% 67.54% 129.59% 139.35% 169.98% 121.27% 100.00%
EY 4.56 3.19 1.66 1.55 1.27 1.78 2.16 13.25%
  YoY % 42.95% 92.17% 7.10% 22.05% -28.65% -17.59% -
  Horiz. % 211.11% 147.69% 76.85% 71.76% 58.80% 82.41% 100.00%
DY 3.19 2.54 1.23 0.85 0.71 1.01 0.85 24.64%
  YoY % 25.59% 106.50% 44.71% 19.72% -29.70% 18.82% -
  Horiz. % 375.29% 298.82% 144.71% 100.00% 83.53% 118.82% 100.00%
P/NAPS 1.40 1.16 2.01 2.25 2.81 3.39 2.36 -8.33%
  YoY % 20.69% -42.29% -10.67% -19.93% -17.11% 43.64% -
  Horiz. % 59.32% 49.15% 85.17% 95.34% 119.07% 143.64% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS